Clinical trial ACTRN12623000404628
Status: Recruiting (according to the registry)Phase 3Latest change: Source: ANZCTR (Australia, New Zealand) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in April 19, 2023 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
- Record number
- ACTRN12623000404628
- Registry
- ANZCTR (Australia, New Zealand) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 172
- Condition (as registered)
- Mild to moderate pain, Anaesthesiology - Pain management
- Countries
- Australia
- Topic in the guide
- Chronic Pain, CBD Cream (Topical)
Timeline
According to the ANZCTR (Australia, New Zealand) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: April 19, 2023
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Chronic Pain: guide page · CBD Cream (Topical): guide page · Thinking of taking part? Which specialist to see